MAPT and Creutzfeldt Jacob disease: In the attempt to find surrogate markers in the serum and CSF of patients with CJD or those that are at risk of developing the disease, Steinacker et al. reported increased neurofilaments (NF’s) and Tau protein in the serum of patients with CJD.